Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)

Abid R. Assali, Joseph Salloum, Stefano Sdringola, Ali Moustapha, Mohammad Ghani, Susan Hale, George Schroth, Ken Fujise, H.Vernon Anderson, Richard W. Smalling, Oscar R. Rosales

Open source

DOI
10.1016/s0002-9149(01)01897-5
Published
2001-10
Container
The American Journal of Cardiology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0002-9149-01-01897-5,
  title = {Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)},
  author = {Abid R. Assali and Joseph Salloum and Stefano Sdringola and Ali Moustapha and Mohammad Ghani and Susan Hale and George Schroth and Ken Fujise and H.Vernon Anderson and Richard W. Smalling and Oscar R. Rosales},
  year = {2001},
  journal = {The American Journal of Cardiology},
  doi = {10.1016/s0002-9149(01)01897-5},
  url = {https://doi.org/10.1016/s0002-9149(01)01897-5}
}

RIS

TY  - JOUR
TI  - Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)
AU  - Abid R. Assali
AU  - Joseph Salloum
AU  - Stefano Sdringola
AU  - Ali Moustapha
AU  - Mohammad Ghani
AU  - Susan Hale
AU  - George Schroth
AU  - Ken Fujise
AU  - H.Vernon Anderson
AU  - Richard W. Smalling
AU  - Oscar R. Rosales
PY  - 2001
JO  - The American Journal of Cardiology
DO  - 10.1016/s0002-9149(01)01897-5
UR  - https://doi.org/10.1016/s0002-9149(01)01897-5
ER  - 

APA

Assali, A. R., Salloum, J., Sdringola, S., Moustapha, A., Ghani, M., Hale, S., Schroth, G., Fujise, K., Anderson, H., Smalling, R. W., & Rosales, O. R. (2001). Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban). The American Journal of Cardiology. https://doi.org/10.1016/s0002-9149(01)01897-5

Source records